BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 19682000)

  • 1. Treatment of angiofibromas of tuberous sclerosis with 5-aminolevulinic acid blue light photodynamic therapy followed by immediate pulsed dye laser.
    Weinberger CH; Endrizzi B; Hook KP; Lee PK
    Dermatol Surg; 2009 Nov; 35(11):1849-51. PubMed ID: 19682000
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted topical and combination laser surgery for the treatment of angiofibromas.
    Bae-Harboe YS; Geronemus RG
    Lasers Surg Med; 2013 Nov; 45(9):555-7. PubMed ID: 24136238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis.
    Weiss ET; Geronemus RG
    Lasers Surg Med; 2010 Jul; 42(5):357-60. PubMed ID: 20583249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy.
    Orringer JS; Sachs DL; Bailey E; Kang S; Hamilton T; Voorhees JJ
    J Cosmet Dermatol; 2010 Mar; 9(1):28-34. PubMed ID: 20367670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmental tuberous sclerosis in a patient presenting as unilateral facial angiofibromas, periungual fibromas and Shagreen patch.
    Sener S; Sasmaz S
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):980-2. PubMed ID: 21845812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia.
    Shafirstein G; Friedman A; Siegel E; Moreno M; Bäumler W; Fan CY; Morehead K; Vural E; Stack BC; Suen JY
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1117-23. PubMed ID: 22106236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy in a patient with facial angiofibromas due to tuberous sclerosis complex.
    Shi M; He S; Chen P; Li Q; Zhu M; Guo J; Jiang L; Wang Q; Peng X; Li S; Li C; Zeng K
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():183-185. PubMed ID: 31398516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of angiofibromas in tuberous sclerosis complex: the effect of topical rapamycin and concomitant laser therapy.
    Park J; Yun SK; Cho YS; Song KH; Kim HU
    Dermatology; 2014; 228(1):37-41. PubMed ID: 24401865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial angiofibromas treated by rapamycin 0.05% ointment and a combined laser therapy.
    Negosanti F; Tengattini V; Gurioli C; Neri I
    J Cosmet Dermatol; 2018 Oct; 17(5):762-765. PubMed ID: 30123982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photodynamic therapy for acne: use of the pulsed dye laser and methylaminolevulinate].
    García-Morales I; Harto A; Fernández-Guarino M; Jaén P
    Actas Dermosifiliogr; 2010 Nov; 101(9):758-70. PubMed ID: 21034706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Angiofibromas in a Tuberous Sclerosis Patient Using Topical Timolol 0.5% Gel.
    Krakowski AC; Nguyen TA
    Pediatrics; 2015 Sep; 136(3):e709-13. PubMed ID: 26304829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of topical 5-aminolevulinic acid-photodynamic therapy with carbon dioxide laser for sebaceous hyperplasia.
    Kim SK; Do JE; Kang HY; Lee ES; Kim YC
    J Am Acad Dermatol; 2007 Mar; 56(3):523-4. PubMed ID: 17317498
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers.
    Alexiades-Armenakas M
    Dermatol Clin; 2007 Jan; 25(1):25-33. PubMed ID: 17126739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of photodynamic therapy and ultrapulse carbon dioxide laser for facial angiofibromas in tuberous sclerosis complex: A case report.
    Wang B; Yao Y; Huang X; Zhang L; Peng D; Zhang G
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102725. PubMed ID: 35041984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients.
    Foster RS; Bint LJ; Halbert AR
    Australas J Dermatol; 2012 Feb; 53(1):52-6. PubMed ID: 22309333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with 5-aminolevulinic acid intralesional injection for pyogenic granuloma.
    Lee DJ; Kim EH; Jang YH; Kim YC
    Arch Dermatol; 2012 Jan; 148(1):126-8. PubMed ID: 22250252
    [No Abstract]   [Full Text] [Related]  

  • 17. Photodynamic therapy following carbon dioxide laser enhances efficacy in the treatment of extramammary Paget's disease.
    Fukui T; Watanabe D; Tamada Y; Matsumoto Y
    Acta Derm Venereol; 2009; 89(2):150-4. PubMed ID: 19325999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of intense pulsed light, combination radiofrequency and intense pulsed light, and blue light in photodynamic therapy for acne vulgaris.
    Taub AF
    J Drugs Dermatol; 2007 Oct; 6(10):1010-6. PubMed ID: 17966178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1) ) in two patients with tuberous sclerosis.
    Mutizwa MM; Berk DR; Anadkat MJ
    Br J Dermatol; 2011 Oct; 165(4):922-3. PubMed ID: 21692776
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of tuberous sclerosis with a giant angiofibroma.
    Wataya-Kaneda M; Yano K; Hosokawa K; Yoshikawa K
    J Dermatol; 1997 Feb; 24(2):132-4. PubMed ID: 9065711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.